secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2026-08-04T20:22:22+00:00
Accession:  0000896264-26-000050
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q2 net loss $21.4M on $223M sales; cuts FY guidance, records $29M Hiya impairment
--------------------------------------------------------------------------------

- Net loss of $21.4M (diluted EPS $(1.16)) vs net income of $9.7M ($0.52) a year ago; adjusted EPS $(0.07) vs $0.74.
- Recorded $29.1M non-cash goodwill impairment on Hiya; Hiya net sales fell 17% to $28M, subscribers down 17%.
- Core Nutritional net sales $192M (-4% YoY); active customers 384,000 (-8%).
- FY2026 guidance slashed: consolidated net sales now $910M (prev $925M-$1.0B), net loss $(11)M (prev $20M-$27M), adj. EPS $0.76 (prev $1.95-$2.29).
- Balance sheet: $169M cash, zero debt; no share repurchases in Q2; $34M remaining authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000050/0000896264-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000050/usna-20260804.htm
  HTML page:      https://secwatch.observer/filing/0000896264-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer